$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11 2016 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Buy | M | 22.13 | 9,754 | 215,856 | 81,413 | 71.7 K to 81.4 K (+13.61 %) |
| Jul 06 2016 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Option Exercise | A | 25.99 | 100,000 | 2,599,000 | 100,000 | |
| Jul 06 2016 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 50,000 | 40 K to 50 K (+25.00 %) |
| Jul 06 2016 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
| Jun 24 2016 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Option Exercise | M | 8.50 | 500 | 4,250 | 0 | |
| Jun 24 2016 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Sell | S | 25.09 | 500 | 12,545 | 9,202 | 9.7 K to 9.2 K (-5.15 %) |
| Jun 24 2016 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Buy | M | 8.50 | 500 | 4,250 | 9,702 | 9.2 K to 9.7 K (+5.43 %) |
| Jun 14 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 22.13 | 8,647 | 191,358 | 54,536 | |
| Jun 14 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 22.13 | 8,647 | 191,358 | 108,771 | 100.1 K to 108.8 K (+8.64 %) |
| Jun 14 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 22.13 | 8,647 | 191,358 | 54,536 | |
| Jun 14 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 22.13 | 8,647 | 191,358 | 108,771 | 100.1 K to 108.8 K (+8.64 %) |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 27.93 | 15,000 | 418,950 | 15,000 | |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 27.93 | 15,000 | 418,950 | 15,000 | |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | M | 18.65 | 1,086 | 20,254 | 0 | |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Sell | S | 27.83 | 1,086 | 30,224 | 0 | 1.1 K to 0 (-100.00 %) |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Buy | M | 18.65 | 1,086 | 20,254 | 1,086 | 0 to 1.1 K |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 27.93 | 15,000 | 418,950 | 15,000 | |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 27.93 | 15,000 | 418,950 | 15,000 | |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 27.93 | 15,000 | 418,950 | 15,000 | |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 27.93 | 15,000 | 418,950 | 15,000 | |
| Jun 10 2016 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 27.93 | 15,000 | 418,950 | 15,000 | |
| May 16 2016 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 26.11 | 4,860 | 126,885 | 49,670 | 54.5 K to 49.7 K (-8.91 %) |
| May 13 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 26.40 | 15,000 | 396,000 | 15,000 | |
| May 13 2016 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 26.40 | 20,000 | 528,000 | 20,000 | |
| May 13 2016 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 26.40 | 25,000 | 660,000 | 25,000 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | Batycky Richard P. | Chief Tech. Off. & ... | Option Exercise | A | 35.53 | 24,255 | 861,780 | 24,255 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 35.53 | 30,163 | 1,071,691 | 30,163 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Option Exercise | A | 35.53 | 27,342 | 971,461 | 27,342 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 35.53 | 26,796 | 952,062 | 26,796 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Option Exercise | A | 35.53 | 24,255 | 861,780 | 24,255 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 35.53 | 26,796 | 952,062 | 26,796 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 35.53 | 68,726 | 2,441,835 | 68,726 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | A | 35.53 | 20,300 | 721,259 | 20,300 | |
| Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 15.49 | 10,591 | 164,055 | 40,172 | |
| Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 6.00 | 4,005 | 24,030 | 0 | |
| Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 5.85 | 14,642 | 85,656 | 0 | |
| Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 15.49 | 10,591 | 164,055 | 429,788 | 419.2 K to 429.8 K (+2.53 %) |
| Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 6.00 | 4,005 | 24,030 | 419,197 | 415.2 K to 419.2 K (+0.96 %) |
| Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 5.85 | 14,642 | 85,656 | 415,192 | 400.6 K to 415.2 K (+3.66 %) |
| Apr 21 2016 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | M | 18.65 | 1,488 | 27,751 | 0 | |
| Apr 21 2016 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Sell | S | 28.68 | 1,488 | 42,676 | 0 | 1.5 K to 0 (-100.00 %) |
| Apr 21 2016 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Buy | M | 18.65 | 1,488 | 27,751 | 1,488 | 0 to 1.5 K |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 18.21 | 10,000 | 182,100 | 0 | |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 17.85 | 2,689 | 47,999 | 0 | |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 22.13 | 542 | 11,994 | 0 | |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 42.26 | 100 | 4,226 | 0 | 100 to 0 (-100.00 %) |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 41.85 | 13,131 | 549,480 | 100 | 13.2 K to 100 (-99.24 %) |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 18.21 | 10,000 | 182,100 | 13,231 | 3.2 K to 13.2 K (+309.50 %) |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 17.85 | 2,689 | 47,999 | 3,231 | 542 to 3.2 K (+496.13 %) |
| Jan 06 2016 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 22.13 | 542 | 11,994 | 542 | 0 to 542 |
| Dec 28 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 5.85 | 10,751 | 62,893 | 0 | |
| Dec 28 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 43.10 | 10,751 | 463,395 | 100,124 | 110.9 K to 100.1 K (-9.70 %) |
| Dec 28 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 5.85 | 10,751 | 62,893 | 110,875 | 100.1 K to 110.9 K (+10.74 %) |
| Dec 24 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 5.85 | 5,342 | 31,251 | 10,751 | |
| Dec 24 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 42.07 | 8,455 | 355,726 | 100,124 | 108.6 K to 100.1 K (-7.79 %) |
| Dec 24 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 43.00 | 5,342 | 229,706 | 108,579 | 113.9 K to 108.6 K (-4.69 %) |
| Dec 24 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 5.85 | 5,342 | 31,251 | 113,921 | 108.6 K to 113.9 K (+4.92 %) |
| Dec 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Option Exercise | M | 22.06 | 7,113 | 156,913 | 9,596 | |
| Dec 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 42.04 | 7,113 | 299,063 | 14,378 | 21.5 K to 14.4 K (-33.10 %) |
| Dec 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Buy | M | 22.06 | 7,113 | 156,913 | 21,491 | 14.4 K to 21.5 K (+49.47 %) |
| Dec 22 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 42.00 | 817 | 34,314 | 108,579 | 109.4 K to 108.6 K (-0.75 %) |
| Dec 22 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Option Exercise | M | 5.85 | 21,499 | 125,769 | 0 | |
| Dec 22 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Option Exercise | M | 6.00 | 17,527 | 105,162 | 0 | |
| Dec 22 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Sell | S | 41.06 | 520 | 21,351 | 9,202 | 9.7 K to 9.2 K (-5.35 %) |
| Dec 22 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Sell | S | 40.62 | 38,506 | 1,564,137 | 9,722 | 48.2 K to 9.7 K (-79.84 %) |
| Dec 22 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Buy | M | 5.85 | 21,499 | 125,769 | 48,228 | 26.7 K to 48.2 K (+80.43 %) |
| Dec 22 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Buy | M | 6.00 | 17,527 | 105,162 | 26,729 | 9.2 K to 26.7 K (+190.47 %) |
| Dec 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 6.00 | 3,277 | 19,662 | 0 | |
| Dec 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 40.00 | 3,277 | 131,080 | 109,396 | 112.7 K to 109.4 K (-2.91 %) |
| Dec 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 6.00 | 3,277 | 19,662 | 112,673 | 109.4 K to 112.7 K (+3.00 %) |
| Dec 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Option Exercise | M | 22.06 | 14,229 | 313,892 | 16,709 | |
| Dec 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 40.00 | 14,229 | 569,160 | 14,378 | 28.6 K to 14.4 K (-49.74 %) |
| Dec 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Buy | M | 22.06 | 14,229 | 313,892 | 28,607 | 14.4 K to 28.6 K (+98.96 %) |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 38.08 | 5,523 | 210,294 | 109,396 | 114.9 K to 109.4 K (-4.81 %) |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 38.06 | 7,106 | 270,481 | 14,378 | 21.5 K to 14.4 K (-33.08 %) |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Sell | S | 38.06 | 964 | 36,689 | 40,713 | 41.7 K to 40.7 K (-2.31 %) |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Sell | S | 38.08 | 7,167 | 272,954 | 9,202 | 16.4 K to 9.2 K (-43.78 %) |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 38.26 | 442 | 16,911 | 54,530 | 55 K to 54.5 K (-0.80 %) |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 38.08 | 11,850 | 451,225 | 400,550 | 412.4 K to 400.6 K (-2.87 %) |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 38.08 | 7,218 | 274,869 | 32,148 | 39.4 K to 32.1 K (-18.34 %) |
| Nov 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 8.50 | 500 | 4,250 | 0 | |
| Nov 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 37.47 | 500 | 18,735 | 71,659 | 72.2 K to 71.7 K (-0.69 %) |
| Nov 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Buy | M | 8.50 | 500 | 4,250 | 72,159 | 71.7 K to 72.2 K (+0.70 %) |
| Nov 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 6.00 | 7,915 | 47,490 | 3,277 | |
| Nov 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 5.85 | 8,907 | 52,106 | 16,093 | |
| Nov 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 6.00 | 7,915 | 47,490 | 114,919 | 107 K to 114.9 K (+7.40 %) |
| Nov 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 5.85 | 8,907 | 52,106 | 107,004 | 98.1 K to 107 K (+9.08 %) |
| Oct 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | M | 5.85 | 32,500 | 190,125 | 0 | |
| Oct 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 31.25 | 3,700 | 115,616 | 71,659 | 75.4 K to 71.7 K (-4.91 %) |
| Oct 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 30.82 | 28,800 | 887,501 | 75,359 | 104.2 K to 75.4 K (-27.65 %) |
| Oct 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Buy | M | 5.85 | 32,500 | 190,125 | 104,159 | 71.7 K to 104.2 K (+45.35 %) |
| Oct 09 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Sell | S | 30.45 | 4,433 | 134,963 | 41,677 | 46.1 K to 41.7 K (-9.61 %) |
| Oct 09 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Sell | S | 29.52 | 1,267 | 37,396 | 46,110 | 47.4 K to 46.1 K (-2.67 %) |
| Oct 09 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Sell | S | 29.82 | 250 | 7,455 | 16,369 | 16.6 K to 16.4 K (-1.50 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 31.89 | 3,219 | 102,658 | 98,097 | 101.3 K to 98.1 K (-3.18 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 30.91 | 531 | 16,413 | 101,316 | 101.8 K to 101.3 K (-0.52 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 15.49 | 910 | 14,096 | 50,763 | |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 15.49 | 54,421 | 842,981 | 51,673 | |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 8.50 | 500 | 4,250 | 0 | |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 5.85 | 70,358 | 411,594 | 14,642 | |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 6.00 | 8,811 | 52,866 | 4,005 | |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.10 | 910 | 27,391 | 412,400 | 413.3 K to 412.4 K (-0.22 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 15.49 | 910 | 14,096 | 413,310 | 412.4 K to 413.3 K (+0.22 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 28.01 | 134,090 | 3,756,142 | 412,400 | 546.5 K to 412.4 K (-24.54 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 15.49 | 54,421 | 842,981 | 546,490 | 492.1 K to 546.5 K (+11.06 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 8.50 | 500 | 4,250 | 492,069 | 491.6 K to 492.1 K (+0.10 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 5.85 | 70,358 | 411,594 | 491,569 | 421.2 K to 491.6 K (+16.70 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 6.00 | 8,811 | 52,866 | 421,211 | 412.4 K to 421.2 K (+2.14 %) |
| Sep 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | M | 6.00 | 13,085 | 78,510 | 0 | |
| Sep 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 31.81 | 6,191 | 196,966 | 71,659 | 77.9 K to 71.7 K (-7.95 %) |
| Sep 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 30.85 | 6,894 | 212,646 | 77,850 | 84.7 K to 77.9 K (-8.14 %) |
| Sep 23 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Buy | M | 6.00 | 13,085 | 78,510 | 84,744 | 71.7 K to 84.7 K (+18.26 %) |
| Aug 27 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 31.37 | 10,000 | 313,700 | 10,000 | |
| Jun 11 2015 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 30.49 | 15,000 | 457,350 | 15,000 | |
| Jun 11 2015 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 30.49 | 15,000 | 457,350 | 15,000 | |
| Jun 11 2015 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 30.49 | 15,000 | 457,350 | 15,000 | |
| Jun 11 2015 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 30.49 | 15,000 | 457,350 | 15,000 | |
| Jun 11 2015 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 30.49 | 15,000 | 457,350 | 15,000 | |
| Jun 11 2015 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 30.49 | 15,000 | 457,350 | 15,000 | |
| Jun 11 2015 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 30.49 | 15,000 | 457,350 | 15,000 | |
| May 15 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 30.16 | 475 | 14,326 | 54,972 | 55.4 K to 55 K (-0.86 %) |
| May 15 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 29.78 | 4,304 | 128,168 | 55,447 | 59.8 K to 55.4 K (-7.20 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 35.74 | 41,191 | 1,472,166 | 41,191 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 7,269 | 0 | 101,847 | 94.6 K to 101.8 K (+7.69 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Option Exercise | A | 35.74 | 35,827 | 1,280,457 | 35,827 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Grant | A | 0.00 | 6,323 | 0 | 21,484 | 15.2 K to 21.5 K (+41.71 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 35.74 | 33,278 | 1,189,356 | 33,278 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Grant | A | 0.00 | 5,872 | 0 | 47,377 | 41.5 K to 47.4 K (+14.15 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | M | 8.14 | 2,698 | 21,962 | 0 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Sell | S | 34.91 | 2,698 | 94,179 | 0 | 2.7 K to 0 (-100.00 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Buy | M | 8.14 | 2,698 | 21,962 | 2,698 | 0 to 2.7 K |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Option Exercise | A | 35.74 | 31,577 | 1,128,562 | 31,577 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Grant | A | 0.00 | 5,573 | 0 | 16,619 | 11 K to 16.6 K (+50.45 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 35.74 | 23,885 | 853,650 | 23,885 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 4,215 | 0 | 59,751 | 55.5 K to 59.8 K (+7.59 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 35.74 | 94,000 | 3,359,560 | 94,000 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 17,000 | 0 | 512,400 | 495.4 K to 512.4 K (+3.43 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Option Exercise | A | 35.74 | 33,278 | 1,189,356 | 33,278 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Grant | A | 0.00 | 5,872 | 0 | 39,366 | 33.5 K to 39.4 K (+17.53 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | A | 35.74 | 33,278 | 1,189,356 | 33,278 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Grant | A | 0.00 | 5,872 | 0 | 71,659 | 65.8 K to 71.7 K (+8.93 %) |
| Jan 15 2015 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | M | 25.45 | 10,000 | 254,500 | 0 | |
| Jan 15 2015 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Sell | S | 44.00 | 10,000 | 440,000 | 0 | 10 K to 0 (-100.00 %) |
| Jan 15 2015 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Buy | M | 25.45 | 10,000 | 254,500 | 10,000 | 0 to 10 K |
| Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Option Exercise | M | 21.52 | 13,371 | 287,744 | 18,750 | |
| Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Option Exercise | M | 21.52 | 42,879 | 922,756 | 32,121 | |
| Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Option Exercise | M | 26.35 | 18,225 | 480,229 | 6,075 | |
| Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Option Exercise | M | 30.46 | 16,803 | 511,819 | 23,517 | |
| Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Option Exercise | M | 30.46 | 6,715 | 204,539 | 40,320 | |
| Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 43.50 | 5,171 | 224,962 | 33,494 | 38.7 K to 33.5 K (-13.37 %) |